Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00282893 · ClinicalTrials.gov registry record · Phase 2
Balloon Prophylaxis of Aneurysmal Vasospasm
A Phase 2 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Phase 2
- Development phase
- 170
- Enrollment target
NCT00282893 is a Phase 2 study that has completed, run by University of California, Davis. The registered enrollment target is 170 participants.
The verdict
NCT00282893, a Phase 2 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 170 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if early transluminal ballooning of the major cerebral arteries prevents severe vasospasm and improves neurological outcome in patients with Fisher Grade III aneurysmal subarachnoid hemorrhage.
Interventions
- PROCEDURE transluminal ballooning
- OTHER currently existing therapies for the treatment of vasospasm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2000-10 |
| Est. Completion | 2006-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00282893
The ClinicalTrials.gov registry entry for NCT00282893 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which transluminal ballooning is the first listed.
NCT00282893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00282893 about?
NCT00282893 is a clinical study titled "Balloon Prophylaxis of Aneurysmal Vasospasm". The purpose of this study is to determine if early transluminal ballooning of the major cerebral arteries prevents severe vasospasm and improves neurological outcome in patients with Fisher Grade III aneurysmal subarachnoid hemorrhage.
What is the current status of trial NCT00282893?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 170 participants. The study started on 2000-10. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00282893?
The interventions under investigation include: transluminal ballooning (PROCEDURE), currently existing therapies for the treatment of vasospasm (OTHER).
Who is sponsoring clinical trial NCT00282893?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.